
COVID-19 cases rising, but public is not worried
New survey examines people’s attitudes as physicians, public health experts prepare for fall respiratory virus season.
Despite increasing cases of COVID-19, Americans apparently feel like they’ve been there, done that, for risk of infection.
A new
The Yahoo-YouGov survey ran Aug. 17 to 21, involving 1,665 adults. In the week before Aug. 19, the
But current reports of COVID-19 infections were not on the radar for 63% of people saying they don’t follow that news very closely or at all. A total of 33% of people to pay attention to COVID-19 infection levels, and 4% were not sure. For age groups, 50% of people aged 65 and older said they were keeping up with those reports, the most of any demographic.
Shots and masks
As flu shot season approaches, 34% of respondents said they would be willing to get another COVID-19 booster shot, while 9% said no and 57% reported they were not boosted. Respondents aged 65 years and older had the strongest reaction, with 57% saying they would get another COVID-19 booster.
Masking up has become less common. Just 12% of participants said they wear a face mask always or most of the time when outside home in the previous week, while 88% said they wear masks some of the time or never.
But most people don’t mind if others wear masks – 9% said they think more of others who wear masks in public, 14% said they think less of others wearing masks, 73% said they don’t judge either way, and 4% were not sure.
Physicians, be aware
Even if the public is not paying attention to COVID-19, physicians should be aware of the new COVID-19 Omicron variant EG.5, nicknamed Eris, according to the
“As people continue to enjoy the warm weather this month and into September when summer ends, they must also remain vigilant, adapting strategies and precautionary measures to ensure that this summer does not give way to complacency in the face of a still formidable adversary: COVID-19,” the AMA advisory said.
Vaccines on schedule
Meanwhile, new vaccines are coming from Pfizer, Moderna, and Novavax, according to officials of CDC and the U.S. Food and Drug Administration. News outlets
The Hill report stated the COVID-19 immunity rate is estimated at 97% for people aged 16 years and older, the CDC and FDA officials said, noting immunity is not a guarantee of protection against illness. That report noted this also will be the first respiratory virus season with vaccines against respiratory syncytial virus (RSV), which has greatest effects in babies and the elderly.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.